Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates
- 1 May 1991
- journal article
- Published by Elsevier in Brain Research
- Vol. 547 (2) , 181-189
- https://doi.org/10.1016/0006-8993(91)90960-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis)Brain Research, 1990
- Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- D2 dopamine receptors in the human brain: heterogeneity based on differences in guanine nucleotide effect on agonist binding, and their presence on corticostriatal nerve terminalsBrain Research, 1989
- Flow dependent changes in the effective surface area of microdialysis probesLife Sciences, 1988
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSFBrain Research, 1987
- Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor densityBrain Research, 1986
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986
- Quantitative computer analysis of autoradiographs utilizing a charge-coupled device solid-state cameraJournal of Neuroscience Methods, 1984
- The L‐dopa on‐off effect in parkinson disease: Treatment by transient drug withdrawal and dopamine receptor resensitizationAnnals of Neurology, 1978
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973